Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
![]() |
Fig. S 4 e f
Lee H et al. (2020) |
Xtr Wt + nog CRISPR
NF11 (in situ hybridization) |
|
|||
![]() |
Fig. S 4 e f
Lee H et al. (2020) |
Xtr Wt + nog CRISPR + rspo2 CRISPR
NF11 (in situ hybridization) |
|
|||
![]() |
fig.7.f
Rothe M et al. (2017) |
Xla Wt + nog + epha4 MO + animal cap explant
NF13 (real time PCR) |
|
|||
![]() |
fig.7.f
Rothe M et al. (2017) |
Xla Wt + nog + sipa1l3 MO + animal cap explant
NF13 (real time PCR) |
|
|||
![]() |
fig.1.e
Eroshkin FM et al. (2016) |
Xla Wt + nog
NF15 (in situ hybridization) |
|
|||
![]() |
fig.1.i
Eroshkin FM et al. (2016) |
Xla Wt + nog
NF15 (in situ hybridization) |
|
|||
![]() |
fig.1.m
Eroshkin FM et al. (2016) |
Xla Wt + nog
NF15 (in situ hybridization) |
|
|||
![]() |
fig.1.q
Eroshkin FM et al. (2016) |
Xla Wt + nog
NF15 (in situ hybridization) |
|
|||
![]() |
fig.4.f
Steventon B and Mayor R (2012) |
Xla Wt + Hsa.NOG
neurula stage (in situ hybridization) |
|
|||
![]() |
fig.4.g
Steventon B and Mayor R (2012) |
Xla Wt + Hsa.NOG
neurula stage (in situ hybridization) |
|